-
中文名稱：pbpA兔多克隆抗體, HRP偶聯(lián)
-
貨號：CSB-PA401992HB01CWV
-
規(guī)格：￥880
-
其他：
產品詳情
-
產品名稱：Rabbit anti-Clostridium botulinum pbpA Polyclonal antibody
-
Uniprot No.：
-
基因名：pbpA
-
別名：pbpA antibody; CBO3083 antibody; CLC_2985 antibody; Penicillin-binding protein 1A antibody; PBP1a) [Includes: Penicillin-insensitive transglycosylase antibody; EC 2.4.1.129 antibody; Peptidoglycan TGase); Penicillin-sensitive transpeptidase antibody; EC 3.4.16.4 antibody; DD-transpeptidase)] antibody
-
宿主：Rabbit
-
反應種屬：Clostridium botulinum
-
免疫原：Recombinant Clostridium botulinum Penicillin-binding protein 1A protein (663-830AA)
-
免疫原種屬：Clostridium botulinum
-
標記方式：HRP
-
克隆類型：Polyclonal
-
抗體亞型：IgG
-
純化方式：>95%, Protein G purified
-
濃度：It differs from different batches. Please contact us to confirm it.
-
保存緩沖液：Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4 -
產品提供形式：Liquid
-
應用范圍：ELISA
-
Protocols：
-
儲存條件：Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
貨期：Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
-
用途：For Research Use Only. Not for use in diagnostic or therapeutic procedures.
產品評價
相關產品
靶點詳情
-
功能：Cell wall formation. Synthesis of cross-linked peptidoglycan from the lipid intermediates. The enzyme has a penicillin-insensitive transglycosylase N-terminal domain (formation of linear glycan strands) and a penicillin-sensitive transpeptidase C-terminal domain (cross-linking of the peptide subunits).
-
亞細胞定位：Cell membrane; Single-pass type II membrane protein.
-
蛋白家族：Glycosyltransferase 51 family; Transpeptidase family
-
數(shù)據(jù)庫鏈接：
KEGG: cbh:CLC_2985
Most popular with customers
-
-
YWHAB Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC, IF, FC
Species Reactivity: Human, Mouse, Rat
-
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC
Species Reactivity: Human
-
-
-
-
-
